A
Alcon Inc. (ALC)
NYQ – Real Time Price. Currency in USD
73.34
-1.13 (-1.52%)
At close: Mar 27, 2026, 4:00 PM EDT
73.41
+0.07 (0.10%)
After-hours: Mar 27, 2026, 6:27 PM EDT
Get all premium features to the best stock analysis tool
NYQ – Real Time Price. Currency in USD
73.34
-1.13 (-1.52%)
At close: Mar 27, 2026, 4:00 PM EDT
73.41
+0.07 (0.10%)
After-hours: Mar 27, 2026, 6:27 PM EDT
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
| Name | Position |
|---|---|
| Dr. Franck Leveiller Ph.D. | SVP of Global Research & Development and Chief Scientific Officer |
| Margaret Buckley | Chief Accounting Officer |
| Mr. David J. Endicott | CEO & Director |
| Mr. Ian Bell | Senior VP & COO |
| Mr. Laurent Attias | Senior VP of Corporate Strategy, Business Development and Licensing (BD&L), M&A |
| Mr. Leon Sergio Duplan Fraustro | Senior VP & President of Americas |
| Mr. Muru Murugappan | Senior VP and Chief Information & Transformation Officer |
| Date | Type | Document |
|---|---|---|
| 2026-01-07 | 6-K | form6-kstrasbourgterminati.htm |
| 2025-12-09 | DFAN14A | tm2533073d1_dfan14a.htm |
| 2025-11-12 | 6-K | form6-kxearningsreleaseand.htm |
| 2025-11-04 | DFAN14A | tm2530178d1_dfan14a.htm |
| 2025-08-19 | 6-K | alc-20250630.htm |
| 2025-08-05 | DEFM14A | defm14a.htm |
| 2025-05-28 | SD | alconformsd31dec2024.htm |
| 2025-04-04 | 6-K | form6-kxagminvite2025.htm |
| 2025-02-25 | 6-K | form6-kxannualreportwrappe.htm |
| 2024-11-12 | 6-K | form6-kxearningsreleaseand.htm |
| Mr. Royce R. Bedward J.D. |
| Senior VP, General Counsel & Corporate Secretary |
| Mr. Timothy C. Stonesifer | Senior VP & CFO |
| Ms. Kimberly Martin | Senior VP and Chief HR & Corporate Communications |